SCN9A and hereditary sensory and autonomic neuropathy: Given the clinical data illustrating that CIP participants experience an altered affective touch perception and that genetic ablation or pharmacological blockade of Nav1.7 in the rodents reduced C-LTMR excitability, we investigated the impact of the CIP participant mutations on C-LTMR excitability and function.